한글목차

세계의 의약품 정밀화학 시장은 2025년 1,364억 2,000만 달러로 추정되고, 2032년까지 2,353억 2,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지 연평균 복합 성장률(CAGR) 8.1%를 보일 것으로 예측됩니다.

그림. 의약품 정밀화학 시장 점유율(%), 2025년 지역별

의약품 정밀화학 시장은 최근 몇 년 동안 큰 성장을 이루고 있습니다. 의약품 정밀화학은 의약품 제형에 사용되는 의약품 활성 성분 또는 원료 약을 의미합니다. 만성 질환 증가, 노인 인구 증가, 바이오 제약 기업에 의한 의약품 개발에 대한 연구 개발 투자 증가 등의 요인이 의약 정밀 화학 수요를 촉진하고 있습니다. 또한 맞춤형 합성 및 제조 서비스는 의약품 제조업체가 비용을 최적화하고 기타 활동에 집중하는 데 도움이 되기 때문에 인기를 끌고 있습니다. 또한 원료제조업체와 제제기업 간의 장기공급에 관한 다양한 계약도 의약정밀화학 시장을 뒷받침하고 있습니다. 그러나 엄격한 규제 체제와 시장 개척 프로세스와 관련된 높은 비용은 시장 성장을 뒷받침하는 과제가 되었습니다. 전반적으로, 세계의 의약품 정밀화학 시장은 앞으로 몇 년 동안 유리한 기회를 보여줄 것으로 예측됩니다.

시장 역학:

의약품 정밀화학 시장은 만성 질환에 걸리기 쉬운 세계 노인 인구 증가, 건강 관리 지출 증가, 생활 습관병의 이환율 증가 등의 요인에 의해 견인되고 있습니다. UN에 따르면 2050년까지 세계 6명 중 1명이 65세 이상이 된다고 합니다. 게다가 제약회사에 의한 의약품 개발을 위한 연구개발비 증가나 수탁제조의 채용이 시장성장의 원동력이 되고 있습니다. 그러나 의약품 승인을 위한 엄격한 규제 환경과 의약품 제조와 관련된 높은 비용과 같은 과제에 직면하고 있습니다. 한편, 원료 제조 공정에서 커스텀 합성 및 제조의 채용 확대가 이해 관계자에게 큰 기회를 가져오고 있습니다. 게다가 저비용의 숙련노동력을 가진 신흥 시장으로의 원약제조 아웃소싱은 시장관계자에게 새로운 길을 열고 있습니다.

본 조사의 주요 특징

• 본 보고서에서는 의약품 정밀화학 세계 시장을 상세하게 분석했으며, 2024년을 기준연도로 한 예측 기간(2025-2032년) 시장 규모 및 복합 연간 성장률(CAGR%)을 제공합니다.
• 또, 다른 부문에 걸친 잠재적인 수익 성장 기회를 밝혀, 이 시장의 매력적인 투자 제안 매트릭스를 해설했습니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
• 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 파라미터에 근거해, 세계의 의약품 정밀화학 시장의 주요 기업을 프로파일 하고 있습니다.
• 본 보고서로부터의 인사이트에 의해 마케팅 담당자나 기업의 경영진은 장래의 제품 발매, 유형 업, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시할 수 있습니다.
• 세계의 의약품 정밀화학 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자에 대응하고 있습니다.

목차:

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 개요

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
• 바이오시밀러 수요 증가
• 정부의 의료비 지출 증가
  • 억제요인
• 규제 준수에 의한 생산 비용의 상승
• 출력을 제한하는 용량 제한
  • 기회
• 미세 화학 제조의 아웃소싱
• 생물제제 및 바이오시밀러 시장의 성장
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 출시/승인
• PEST 분석
• PORTER 분석
• 합병과 인수 시나리오

제4장 의약품 정밀화학 시장 - 코로나 바이러스(COVID-19) 유행의 영향

• COVID-19 역학
• 공급측과 수요측의 분석
• 경제에 미치는 영향

제5장 의약품 정밀화학 시장 : 유형별, 2020-2032년

• 전매특허
• 비 전매특허

제6장 의약품 정밀화학 시장 : 제품별, 2020-2032년

• 기본적인 구성요소
• 고도 중간체
• 유효성분

제7장 의약품 정밀화학 시장 : 용도별, 2020-2032년

• 심혈관계
• 신경학적
• 종양학
• 감염증
• 대사 시스템
• 당뇨병
• 호흡기
• 위장
• 점막 골격
• 기타

제8장 의약품 정밀화학 시장 : 지역별, 2020-2032년

• 북미
• 유럽
• 아시아태평양
• 중동 및 아프리카
• 라틴아메리카

제9장 경쟁 구도

• 기업 프로파일
  • Denisco
  • Albemarle Corporation
  • Kenko Corporation
  • GRACE
  • CHEMADA
  • JMP Statistical Discovery LLC.
  • Pfizer Inc.
  • GSK plc

제10장 섹션

• 조사 방법
• 출판사에 대해

영문목차

Global Pharmaceutical Fine Chemicals Market is estimated to be valued at USD 136.42 Bn in 2025 and is expected to reach USD 235.32 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.1% from 2025 to 2032.

Figure. Pharmaceutical Fine Chemicals Market Share (%), By Region 2025

The pharmaceutical fine chemicals market has been witnessing significant growth over the past few years. Pharmaceutical fine chemicals refer to active pharmaceutical ingredients or bulk drug substances which are used in pharmaceutical formulations. Factors, such as rising prevalence of chronic diseases, increasing elderly population, and growing research and development investments in drug development by biopharmaceutical companies, are fueling the demand for pharmaceutical fine chemicals. Furthermore, custom synthesis and manufacturing services are gaining traction as they help drug manufacturers optimize costs and focus on other core activities. Various agreements between Active Pharmaceutical Ingredients makers and drug formulation businesses for long term supply are also propelling the pharmaceutical fine chemicals market. However, stringent regulatory framework and high costs associated with drug development processes pose challenges to boost the market growth. Overall, the global pharmaceutical fine chemicals market is anticipated to showcase lucrative opportunities in the coming years.

Market Dynamics:

The pharmaceutical fine chemicals market is driven by factors such as growing geriatric population globally prone to chronic diseases, rising healthcare expenditure, and increasing incidence of lifestyle diseases. As per the United Nations, by 2050, one in six people in the world will be over age 65. Furthermore, increasing R&D spending on drug development by pharmaceutical companies and the adoption of contract manufacturing are fueling the market growth. However, the market faces challenges from stringent regulatory environment for drug approval and high costs associated with drug manufacturing. On the other hand, the growing adoption of custom synthesis and manufacturing in the API production process presents significant opportunities for stakeholders. Additionally, outsourcing of API manufacturing to emerging markets with low-cost skilled labor is opening new avenues for market players.

Key features of the study:

• This report provides an in-depth analysis of the global pharmaceutical fine chemicals market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global pharmaceutical fine chemicals market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Denisco, Albemarle Corporation, Kenko Corporation, GRACE, CHEMADA, JMP Statistical Discovery LLC., Pfizer Inc., GSK plc.,
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global pharmaceutical fine chemicals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Detailed Segmentation:

• Pharmaceutical Fine Chemicals Market, By Type
  • Proprietary
  • Non Proprietary
• Pharmaceutical Fine Chemicals Market, By Product
  • Basic Building Blocks
  • Advanced Intermediates
  • Active Ingredients
• Pharmaceutical Fine Chemicals Market, By Application
  • Cardiovascular
  • Neurological
  • Oncological
  • Infectious Diseases
  • Metabolic System
  • Diabetes
  • Respiratory
  • Gastrointestinal
  • Mucoskeletal
  • Others
• Pharmaceutical Fine Chemicals Market, By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa
• Company Profiles
  • Denisco
  • Albemarle Corporation
  • Kenko Corporation
  • GRACE
  • CHEMADA
  • JMP Statistical Discovery LLC.
  • Pfizer Inc.
  • GSK plc.

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Overview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Type
  • Market Snippet, By Product
  • Market Snippet, By Application
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Rising Demand for Biosimilars
• Increasing Government Healthcare Spending
  • Restraints
• Regulatory Compliance Increasing Production Costs
• Capacity Limitations Restricting Output
  • Opportunities
• Outsourcing of Fine Chemicals Production
• Growth in Biologics and Biosimilars Market
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Pharmaceutical Fine Chemicals Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Pharmaceutical Fine Chemicals Market, By Type, 2020 - 2032 (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Proprietary
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
• Non Proprietary
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2032, (US$ Bn)

6. Pharmaceutical Fine Chemicals Market, By Product, 2020 - 2032 (US$ Bn)

• Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2032, (US$ Bn)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Basic Building Blocks
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2032, (US$ Bn)
• Advanced Intermediates
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2032, (US$ Bn)
• Active Ingredients
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2032, (US$ Bn)

7. Pharmaceutical Fine Chemicals Market, By Application, 2020 - 2032 (US$ Bn)

• Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2032, (US$ Bn)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Cardiovascular
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2032, (US$ Bn)
• Neurological
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2032, (US$ Bn)
• Oncological
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2032, (US$ Bn)
• Infectious Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2032, (US$ Bn)
• Metabolic System
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2032, (US$ Bn)
• Diabetes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2032, (US$ Bn)
• Respiratory
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2032, (US$ Bn)
• Gastrointestinal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2032, (US$ Bn)
• Mucoskeletal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2032, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2032, (US$ Bn)

8. Pharmaceutical Fine Chemicals Market, By Region, 2020 - 2032 (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 - 2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032,(US$ Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest Of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Asean
    • Rest Of Asia Pacific
• Middle East & Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2032,(US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032,(US$ Bn)
    • Mexico
    • Argentina
    • Brazil

9. Competitive Landscape

• Company Profiles
  • Denisco
    • Company Highlights
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • Albemarle Corporation
    • Company Highlights
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • Kenko Corporation
    • Company Highlights
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • GRACE
    • Company Highlights
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • CHEMADA
    • Company Highlights
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • JMP Statistical Discovery LLC.
    • Company Highlights
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • GSK plc
    • Company Highlights
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Analyst Views

10. Section

• Research Methodology
• About us